Elevated serum interleukin-6 is predictive of coronary artery disease in intermediate risk overweight patients referred for coronary angiography

The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease

(2016) Tsuyoshi Shirai et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Predictive Validity of the American College of Cardiology/American Heart Association Pooled Cohort Equations in Predicting All-Cause and Cardiovascular Disease–Specific Mortality in a National Prospective Cohort Study of Adults in the United States

(2016) Paul D. Loprinzi et al.   MAYO CLINIC PROCEEDINGS

HDL cholesterol, leptin and interleukin-6 predict high risk coronary anatomy assessed by CT angiography in patients with stable chest pain

(2015) Chiara Caselli et al.   ATHEROSCLEROSIS

Association of interleukin-6 gene polymorphism with coronary artery disease: an updated systematic review and cumulative meta-analysis

(2015) Haifeng Hou et al.   INFLAMMATION RESEARCH

Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease

(2015) Jaskanwal D. Sara et al.   JACC-Cardiovascular Interventions

Inflammation and Atherosclerosis

(2014) Joshua Hartman et al.   Cardiology in Review

Comparison of cardiovascular disease risk calculators

(2014) G. Michael Allan et al.   CURRENT OPINION IN LIPIDOLOGY

Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction

(2014) Thomas M. Maddox et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

(2013) Neil J. Stone et al.   CIRCULATION

Association of interleukin-6 circulating levels with coronary artery disease: A meta-analysis implementing mendelian randomization approach

(2012) Wenquan Niu et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Serum interleukin-6 concentration reflects the extent of asymptomatic left ventricular dysfunction and predicts progression to heart failure in patients with stable coronary artery disease

(2011) Bartosz Hudzik et al.   CYTOKINE

Serial Analyses of C-Reactive Protein and Myeloperoxidase in Acute Coronary Syndrome

(2009) Flávia K. Borges et al.   CLINICAL CARDIOLOGY

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

(2008) Mark C. Genovese et al.   ARTHRITIS AND RHEUMATISM

Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases

(2008) Hiroyuki Oka et al.   HEART AND VESSELS

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE